Letters
Rational Testing
No evidence base for monitoring aminoglycoside levels
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7264 (Published 30 October 2012) Cite this as: BMJ 2012;345:e7264- James P McCormack, professor
- 1University of British Columbia, Vancouver, BC, Canada
- james.mccormack{at}ubc.ca
I was intrigued by Banerjee and colleagues’ statements that “monitoring of therapy is essential to ensure optimal treatment and prevent toxicity” and this article “reviews the available evidence for this evolving topic.”1
It is my understanding that the evidence base to support measuring aminoglycoside concentrations is weak for multiple dose …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.